PM Society Awards
UCB presentation highlights impacts of epilepsy on daily life
The data underlines the consequences of disrupted sleep for patients and caregivers
EpilepsyMeds receives Highly Commended recognition at Excellence in Healthcare Partnership Awards 2026
EpilepsyMeds received Highly Commended recognition at the Excellence in Healthcare Partnership Awards 2026, celebrating the collaboration between Desitin Pharma, ChangeMed and Genetic Digital in advancing epilepsy care.
UCB’s Fintepla shows positives results for Lennox-Gastaut syndrome
The study demonstrated a sustained reduction in seizures for patients
Genetic Digital Wins Silver at PM Society Digital Awards for Epilepsy Meds Clinical Support App
Genetic Digital wins Silver at the PM Society Digital Awards for Epilepsy Meds, a clinical support app developed with Desitin and ChangeMed to aid patient-specific prescribing in epilepsy care.
Genetic Digital Shortlisted for PM Society Digital Award for Epilepsy Meds App
Genetic Digital has been shortlisted for a PM Society Digital Award for Epilepsy Meds, a mobile-first app that helps healthcare professionals make safer, patient-specific prescribing decisions in epilepsy care. The...
UCB shares promising results for fenfluramine in ultra-rare form of epilepsy
CDKL5 deficiency disorder occurs in approximately one in 40,000 to 60,000 live births
PM Society Awards 2025 – tickets now on sale
This year's Awards will take place on Friday 14 March at JW Marriott Grosvenor House in London
Takeda shares late-stage results for investigational soticlestat in rare epileptic disorders
Dravet syndrome and Lennox-Gastaut syndrome are drug-resistant to many anti-seizure medications
EC approves UCB’s Fintepla to treat severe form of epilepsy
Lennox-Gastaut syndrome affects around two in 10,000 people in the EU and usually begins in early childhood
WHO publishes brief calling for integrated approach to epilepsy treatment
Epilepsy affects over 50 million people globally and accounts for 125,000 death per year
NHS to roll out brain laser therapy for epilepsy patients
There are around 600,000 people living with epilepsy across the UK
